Credit Suisse’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$308K Buy
38,208
+2,437
+7% +$21.6K ﹤0.01% 2812
2023
Q4
$356K Sell
35,771
-5,007
-12% -$39.3K ﹤0.01% 2875
2023
Q3
$326K Buy
40,778
+4,274
+12% +$42.9K ﹤0.01% 2902
2023
Q2
$402K Buy
36,504
+10,044
+38% +$103K ﹤0.01% 2888
2023
Q1
$273K Buy
26,460
+2,901
+12% +$34.2K ﹤0.01% 3027
2022
Q4
$259K Sell
23,559
-362
-2% -$4.65K ﹤0.01% 3096
2022
Q3
$372K Buy
23,921
+92
+0.4% +$2.02K ﹤0.01% 2969
2022
Q2
$546K Buy
+23,829
New +$510K ﹤0.01% 2784

Other funds holding DH

Credit Suisse's DH Position: Q1 2024 in Review

Credit Suisse increased its Definitive Healthcare (DH) stake by 6.8% in Q1 2024, buying an estimated $21.6K and bringing the position to 38,208 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2812.

Credit Suisse first reported a position in DH in Q2 2022 and has held it in 8 quarters since. The position peaked at $546K in Q2 2022. 144 funds tracked by Wall St. Rank hold DH as of Q1 2024.

  • Credit Suisse held 38,208 shares of Definitive Healthcare worth $308K as of Q1 2024.
  • Credit Suisse bought 2,437 Definitive Healthcare shares in Q1 2024, an estimated $21.6K.
  • Definitive Healthcare made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2812 holding.
  • Credit Suisse first reported a position in Definitive Healthcare in Q2 2022 and has held it in 8 quarters since.
  • Credit Suisse's Definitive Healthcare position peaked at $546K in Q2 2022.
  • 144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.